Acute promyelocytic leukemia

Peter H. Wiernik; Robert E. Gallagher; Martin S. Tallman

doi:10.1007/978-1-4614-3764-2_23

Acute promyelocytic leukemia

Peter H. Wiernik^*, Robert E. Gallagher, Martin S. Tallman

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Abstract

Acute promyelocytic leukemia (APL) is designated M3 in the French-American-British (FAB) classification. Because of its unique clinical features and unique response to certain differentiation inducing agents, and because of our advanced understanding of the molecular biology of this leukemia, APL deserves to be presented and discussed in detail, apart from the other acute myeloid leukemias.

Original language	English (US)
Title of host publication	Neoplastic Diseases of the Blood
Publisher	Springer New York
Pages	403-453
Number of pages	51
ISBN (Electronic)	9781461437642
ISBN (Print)	1461437636, 9781461437635
DOIs	https://doi.org/10.1007/978-1-4614-3764-2_23
State	Published - Nov 1 2013

Keywords

All-trans retinoic acid
Arsenic trioxide
Pseudotumor cerebri
Translocation 15;17

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-1-4614-3764-2_23

Cite this

@inbook{9a6382a8327341b8a2ea9af818dbc7c1,

title = "Acute promyelocytic leukemia",

abstract = "Acute promyelocytic leukemia (APL) is designated M3 in the French-American-British (FAB) classification. Because of its unique clinical features and unique response to certain differentiation inducing agents, and because of our advanced understanding of the molecular biology of this leukemia, APL deserves to be presented and discussed in detail, apart from the other acute myeloid leukemias.",

keywords = "All-trans retinoic acid, Arsenic trioxide, Pseudotumor cerebri, Translocation 15;17",

author = "Wiernik, {Peter H.} and Gallagher, {Robert E.} and Tallman, {Martin S.}",

year = "2013",

month = nov,

day = "1",

doi = "10.1007/978-1-4614-3764-2_23",

language = "English (US)",

isbn = "1461437636",

pages = "403--453",

booktitle = "Neoplastic Diseases of the Blood",

publisher = "Springer New York",

}

TY - CHAP

T1 - Acute promyelocytic leukemia

AU - Wiernik, Peter H.

AU - Gallagher, Robert E.

AU - Tallman, Martin S.

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Acute promyelocytic leukemia (APL) is designated M3 in the French-American-British (FAB) classification. Because of its unique clinical features and unique response to certain differentiation inducing agents, and because of our advanced understanding of the molecular biology of this leukemia, APL deserves to be presented and discussed in detail, apart from the other acute myeloid leukemias.

AB - Acute promyelocytic leukemia (APL) is designated M3 in the French-American-British (FAB) classification. Because of its unique clinical features and unique response to certain differentiation inducing agents, and because of our advanced understanding of the molecular biology of this leukemia, APL deserves to be presented and discussed in detail, apart from the other acute myeloid leukemias.

KW - All-trans retinoic acid

KW - Arsenic trioxide

KW - Pseudotumor cerebri

KW - Translocation 15;17

UR - http://www.scopus.com/inward/record.url?scp=84929526130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929526130&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-3764-2_23

DO - 10.1007/978-1-4614-3764-2_23

M3 - Chapter

AN - SCOPUS:84929526130

SN - 1461437636

SN - 9781461437635

SP - 403

EP - 453

BT - Neoplastic Diseases of the Blood

PB - Springer New York

ER -

Acute promyelocytic leukemia

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this